Dario Smart Glucose Monitor Receives FDA Approval

NEW YORK (February 25, 2016)—The U.S. FDA recently opened the doors to new mobile health technology to the millions of Americans managing their diabetes by granting an important 510K clearance for the Dario Blood Glucose Monitoring System for use in the U.S.

LabStyle Innovations, a creator of innovative mobile and digital tools that empower and engage users to lead healthier lives, is set to roll out their flagship product, The Dario Smart Diabetes Management Solution in the U.S. The Dario is a platform for diabetes management that combines an all-in-one blood glucose meter, native smartphone app (iOS & Android), website portal and a wide variety of treatment tools to support more proactive and better informed decisions by users living with diabetes, their doctors and health care systems. They will be exhibiting the Dario at Medtrade Spring at booth #168.

With access to both real-time and historical blood glucose data, Dario is designed to spot patterns, recommend the right treatments and support behavior change efforts. The platform combines an all-in-one, blood glucose meter, smartphone application (iOS & Android), website application and treatment tools to support more proactive and better-informed decisions by patients, doctors and health care systems. The information can be seamlessly integrated to the physician or other health care provider. Younger Dario users can have readings sent via text to a parent/teacher or school nurse.

In addition to providing glucose levels within seconds as well as charts and personalized information, the Dario has integrated popular apps such as RunKeeper, helping patients better manage exercise and fitness activities, and FatSecret, which allows for better food intake management.

The feedback from early adopters in other nations such as Canada, United Kingdom, Australia and Finland has been overwhelmingly positive.

Visit mydario.com for more information.